Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–8 of 8 trials
Active filters
Clinical trials found
Published and searchable clinical trials
Searching for clinical trials...
NCT04005690
- Conditions
- Borderline Resectable Pancreatic Ductal Adenocarcinoma, Digestive System Diseases, Digestive System Neoplasms, +13 more
- Locations
-
- OHSU Knight Cancer Institute Portland, Oregon, United States
NCT05518903
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +10 more
- Locations
-
- Mayo Clinic in Rochester Rochester, Minnesota, United States
NCT06595160
- Conditions
- Borderline Resectable Pancreatic Ductal Adenocarcinoma, Digestive System Diseases, Digestive System Neoplasms, +8 more
- Locations
-
- Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States
Not Yet Recruiting
Samuraciclib for the Treatment of Patients With Resectable, Borderline Resectable, or Locally Advanced Basal Pancreatic Cancer
NCT07645651
- Conditions
- Borderline Resectable Pancreatic Ductal Adenocarcinoma, Locally Advanced Pancreatic Ductal Adenocarcinoma, Resectable Pancreatic Ductal Adenocarcinoma
- Locations
-
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
NCT03970252
- Conditions
- Borderline Resectable Pancreatic Adenocarcinoma, Resectable Pancreatic Ductal Adenocarcinoma
- Locations
-
- UCLA / Jonsson Comprehensive Cancer Center Los Angeles, California, United States
NCT02178709
- Conditions
- Neoplasms, Resectable Pancreatic Ductal Adenocarcinoma
- Locations
-
- Indiana University Simon Cancer Center Indianapolis, Indiana, United States
Active, Not Recruiting
A Study to Determine if the Drug, Pyrvinium Pamoate, is Safe and Tolerable in Patients With Pancreatic Cancer
NCT05055323
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +13 more
- Locations
-
- Thomas Jefferson University Philadelphia, Pennsylvania, United States
Active, Not Recruiting
NBTXR3 Activated by Radiation Therapy for the Treatment of Locally Advanced or Borderline-Resectable Pancreatic Cancer
NCT04484909
- Conditions
- Borderline Resectable Pancreatic Adenocarcinoma, Digestive System Diseases, Digestive System Neoplasms, +9 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States